Malaysia at a glance
- Population
- 36.0 million 2025
- Life expectancy at birth
- 76.8 years, 2024
- People aged 65 and over
- 8.0 % of people, 2025
- Health spending per person
- 450 US$ per person, 2023
- Doctors
- 2.34 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Malaysia Parenteral Nutrition Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$10.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $13.2 Mn | — | — |
| 2025 (base) | $14.0 Mn | +$0.8 Mn | — |
| 2026 (forecast) | $14.9 Mn | +$0.9 Mn | +6.2% |
| 2027 (forecast) | $15.8 Mn | +$0.9 Mn | +12.8% |
| 2028 (forecast) | $16.8 Mn | +$1.0 Mn | +19.8% |
| 2029 (forecast) | $17.8 Mn | +$1.0 Mn | +27.2% |
| 2030 (forecast) | $18.9 Mn | +$1.1 Mn | +35.1% |
| 2031 (forecast) | $20.1 Mn | +$1.2 Mn | +43.5% |
| 2032 (forecast) | $21.3 Mn | +$1.2 Mn | +52.4% |
| 2033 (forecast) | $22.6 Mn | +$1.3 Mn | +61.8% |
| 2034 (forecast) | $24.0 Mn | +$1.4 Mn | +71.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $14.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $24.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, setting and end user (see all) |
| Key players | Fresenius Kabi AG, Baxter International, B. Braun, ICU Medical, Otsuka Pharmaceutical Co., Ltd. (see all) |
| Regulator in Malaysia | NPRASource: National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Parenteral nutrition feeds patients through a vein when they cannot eat or absorb food through the gut.
Key segments of the parenteral Nutrition market include product (Amino Acids, Lipid Emulsions and Carbohydrates) and setting (Hospitals and Home Care).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the parenteral Nutrition market.
Ready-to-use formulations, biosimilars and supply security programmes give the parenteral Nutrition market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the parenteral Nutrition market.
The parenteral Nutrition market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines must be registered with the Drug Control Authority, which works through the National Pharmaceutical Regulatory Agency (NPRA).[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2]
[1] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
[2] Ministry of Health Malaysia. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for parenteral Nutrition. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Malaysia.
What doctors and scientists are doing in Parenteral Nutrition right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia
Medical Devices · Malaysia
OTC & Nutraceuticals · Malaysia
Healthcare Services · Malaysia
Healthcare Services · Malaysia
OTC & Nutraceuticals · Malaysia
Medical Devices · Malaysia